Venomyx Therapeutics

Modern Universal Antivenom

Company Details

At Venomyx we are developing and bringing to market novel antitoxin therapeutics to make treatment safe, effective, and available around the world.

The first market we are addressing is the large ($1B) and highly underserved snake antivenom market. In 2017, over 5 Million people around the world will be bitten by a venomous snake. Of those, approximately 125,000 of them will die and many thousands more will be permanently disabled.

Currently available antivenom relies on antiquated medical technology in which large animals such as horses are injected with snake venom to produce anitobodes. This results in a product with limited efficacy, dangerous side effects, and expensive production process.

We are creating the world’s first modern and portable antivenom that harnesses the power of modern biotechnology to provide a universal treatment for snakebite. Our antivenom has already shown preclinical success as a safer, more effective, and more affordable treatment for the millions of people affected by snakebite.

Company People

Dan Dempsey

Dan Dempsey
CEO & Co-Founder

Deepankar Roy

Deepankar Roy
COO & Co-Founder

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.